首页|First Affiliated Hospital of Shandong First Medical University Reports Findings in Artificial Intelligence (Artificial Intelligence- Assisted Perfusion Density a s Biomarker for Screening Diabetic Nephropathy)

First Affiliated Hospital of Shandong First Medical University Reports Findings in Artificial Intelligence (Artificial Intelligence- Assisted Perfusion Density a s Biomarker for Screening Diabetic Nephropathy)

扫码查看
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News – New research on Artificial Intelligence is the subject of a report. According to news reporting originating in Jinan, People’s Republic of China, by NewsRx journalists, research stated, “To identify a reliable biomarker for screening diabetic nephropathy (DN) using artificial intelligence (AI)- assisted ultra-widefield swept-source optical coherence tomography angiography (UWF SS-OCTA). This study analyzed data from 169 patients (287 e yes) with type 2 diabetes mellitus (T2DM), resulting in 15,211 individual data points.”

JinanPeople’s Republic of ChinaAsiaArtificial IntelligenceBiomarkersDiabetes ComplicationsDiabetes MellitusDiabetic NephropathyDiagnostics and ScreeningEmerging TechnologiesHealth and MedicineKidney Diseases and ConditionsMachine LearningNephrologyNephropathyNutritional and Metabolic Diseases and Conditions

2024

Robotics & Machine Learning Daily News

Robotics & Machine Learning Daily News

ISSN:
年,卷(期):2024.(Oct.29)